S2Medical AB (publ)
STO:S2M
Intrinsic Value
The intrinsic value of one S2M stock under the Base Case scenario is 0.0301 SEK. Compared to the current market price of 0.0135 SEK, S2Medical AB (publ) is Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
S2Medical AB (publ)
Fundamental Analysis

Revenue & Expenses Breakdown
S2Medical AB (publ)
Balance Sheet Decomposition
S2Medical AB (publ)
Current Assets | 5.7m |
Cash & Short-Term Investments | 1m |
Receivables | 2.3m |
Other Current Assets | 2.3m |
Non-Current Assets | 12.4m |
PP&E | 402k |
Intangibles | 12m |
Free Cash Flow Analysis
S2Medical AB (publ)
SEK | |
Free Cash Flow | SEK |
Earnings Waterfall
S2Medical AB (publ)
Revenue
|
14.9m
SEK
|
Cost of Revenue
|
-766k
SEK
|
Gross Profit
|
14.1m
SEK
|
Operating Expenses
|
-8.3m
SEK
|
Operating Income
|
5.8m
SEK
|
Other Expenses
|
-20k
SEK
|
Net Income
|
5.8m
SEK
|
S2M Profitability Score
Profitability Due Diligence
S2Medical AB (publ)'s profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
S2Medical AB (publ)'s profitability score is 42/100. The higher the profitability score, the more profitable the company is.
S2M Solvency Score
Solvency Due Diligence
S2Medical AB (publ)'s solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
S2Medical AB (publ)'s solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
S2M Price Targets Summary
S2Medical AB (publ)
Dividends
Current shareholder yield for S2M is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one S2M stock under the Base Case scenario is 0.0301 SEK.
Compared to the current market price of 0.0135 SEK, S2Medical AB (publ) is Undervalued by 55%.